Xiyuan Wang | social psychology | Best Researcher Award

Posted on by ScienceFather

Xiyuan Wang | social psychology | Best Researcher Award

Professor at Donghua University, China.

Professor Xiyuan Wang is a distinguished academic and researcher in industrial economics and design, affiliated with Donghua University. His expertise extends to advising on industry policy as part of a think tank for the Shanghai Municipal Government and as a key figure in the China Industrial Design Association. With multiple accolades, including national and provincial awards, Professor Wang’s research has significantly influenced China’s industrial and cultural sectors. He has spearheaded numerous research projects, contributing to both academic advancements and policy development, making him a prominent thought leader in industrial design and economic research.

Publication Profile

Scopus

Educational Background

Professor Wang earned his Ph.D. from the ISCTE-University Institute of Lisbon, a premier European institution recognized for its business and social sciences programs. Following his doctorate, he completed a postdoctoral fellowship in industrial economics, allowing him to deepen his understanding of economic frameworks in industrial settings. His education has provided a solid foundation in both theoretical and applied economics, with an emphasis on cross-cultural business research. This academic background has shaped his career and expertise, positioning him as a respected authority in industrial economics and design within academic and industry circles.

Experience

Throughout his career, Professor Wang has held influential roles in academia and industry advisory capacities. As a professor at Donghua University, he has educated and mentored future leaders in industrial economics. Beyond academia, he serves as an expert on the Shanghai Municipal Government’s think tank and is a committee member of the China Industrial Design Association. His responsibilities also include evaluating the Industrial Design discipline for China’s Ministry of Education. These roles highlight his diverse experience and commitment to advancing both academic knowledge and practical applications within China’s industrial landscape.

Research Focus

Professor Wang’s research primarily focuses on industrial economics and the economic impacts of industrial design. His work emphasizes the integration of economic principles with design innovation to promote sustainable industrial growth. He is also involved in researching economic policy for industrial advancement, with a particular interest in the cultural industries. His role as a researcher for the China Institute of Industrial Economics underscores his dedication to studying China’s industrial framework, contributing to policies that shape industry standards. His research contributions have directly impacted China’s approach to industrial and cultural economic development.

Awards and honors

Professor Wang has received numerous awards that underscore his contributions to industrial economics and design. His honors include the prestigious “Cultural Industry Promotion Award” from the Ministry of Culture of China and the “Excellent Research Achievement Award” from the Ministry of Commerce of China. These awards reflect national recognition of his contributions to advancing industrial and cultural sectors through innovative research. He has also been recognized at the provincial and ministerial levels, further affirming his role as a leading figure in industrial research and his influence in shaping policy and academic frameworks in China.

Conclusion

Professor Wang Xiyuan is a strong candidate for the Best Researcher Award, given his outstanding academic credentials, contributions to industrial economics, and influence in both governmental and industrial sectors. His accolades and project leadership reflect his dedication and substantial achievements in the field. With minor enhancements in international engagement and publication reach, Professor Wang could elevate his contributions to even greater heights, further establishing his reputation as a leading researcher in industrial economics and design.

Publication Top Notes

“Exploring the Impact of AI Enhancement on the Sports App Community: Analyzing Human-Computer Interaction and Social Factors Using a Hybrid SEM-ANN Approach”

Authors: Xie, G., Wang, X.

Citation: Xie, G., & Wang, X. (2024). Exploring the impact of AI enhancement on the sports app community: Analyzing human-computer interaction and social factors using a hybrid SEM-ANN approach. International Journal of Human-Computer Interaction.

“Research on the Human-Computer Interaction Interface Design of Intelligent Luggage”

Authors: Wang, X., Yi, X.

Citation: Wang, X., & Yi, X. (2022). Research on the human-computer interaction interface design of intelligent luggage. Journal of Physics: Conference Series, 2337(1), 012019.

“Theoretical Model on Transformation Factors of Scientific and Technological Achievements under the Belt and Road Initiative”

Authors: Wang, X., Zhou, Y., Zhang, Z., Pang, X., Yan, D.

Citation: Wang, X., Zhou, Y., Zhang, Z., Pang, X., & Yan, D. (2021). Theoretical model on transformation factors of scientific and technological achievements under the Belt and Road Initiative. Journal of Donghua University (English Edition), 38(6), 557–568.

“Functional Requirements of FPS Mobile Games Users Based on KANO Model”

Authors: Wang, X., Chen, D., Fu, T.

Citation: Wang, X., Chen, D., & Fu, T. (2021). Functional requirements of FPS mobile games users based on KANO model. Advances in Intelligent Systems and Computing, 1233 AISC, 278–284.

“Information Interface of Artificial Intelligence Medical Device Information”

Authors: Wang, X.Y., Fu, T., Zhang, Y., Yan, D.

Citation: Wang, X.Y., Fu, T., Zhang, Y., & Yan, D. (2020). Information interface of artificial intelligence medical device information. Advances in Intelligent Systems and Computing, 1117 AISC, 1293–1303.

“Comparative Study on Energy Saving of Low-Carbon Materials in Sanitary Ware Development”

Authors: Wang, X.Y.

Citation: Wang, X.Y. (2018). Comparative study on energy saving of low-carbon materials in sanitary ware development. Materials Science Forum, 917 MSF, 289–293.

“Comparative Research on Energy-Saving Performance of New Energy Vehicles”

Authors: Wang, X.Y., Liu, Y.

Citation: Wang, X.Y., & Liu, Y. (2014). Comparative research on energy-saving performance of new energy vehicles. Applied Mechanics and Materials, 602-605, 214–219.

“Study on Circulation Application and Energy-Conservation Management Based on Exhibition Project”

Authors: Wang, X., Xiang, W., Ya’nan, W., Han, J.

Citation: Wang, X., Xiang, W., Ya’nan, W., & Han, J. (2012). Study on circulation application and energy-conservation management based on exhibition project. Applied Mechanics and Materials, 121-126, 2906–2910.

“R&D on Wollastonite-Based Energy-Saving Construction Materials”

Authors: Wang, X., Wu, X., Li, Y.

Citation: Wang, X., Wu, X., & Li, Y. (2011). R&D on wollastonite-based energy-saving construction materials. Applied Mechanics and Materials, 99-100, 1005–1013.

“Study on Comfortability of the Sports Shoes’ Material Interface”

Authors: Wang, X., Wu, X., Han, J.

Citation: Wang, X., Wu, X., & Han, J. (2011). Study on comfortability of the sports shoes’ material interface. Advanced Materials Research, 332-334, 1984–1991.

Sr. Gotfrida Marandu | Breast Cancer | Best Researcher Award

Posted on by ScienceFather

Sr. Gotfrida Marandu | Breast Cancer | Best Researcher Award

Sr. Gotfrida Marandu at Catholic University of Health and Allied Sciences , Tanzania.

Sr. Gotfrida M. Marandu is a dedicated Tanzanian nurse, educator, and researcher with a career spanning over two decades in healthcare education, administration, and clinical practice. She has held various influential roles, including lecturer and quality assurance officer at CUHAS, where she shapes the next generation of healthcare professionals. Her work spans nursing education, healthcare management, and cancer care, making her an advocate for quality healthcare in Tanzania. Passionate about advancing nursing practices and improving healthcare outcomes, Sr. Gotfrida’s contributions are rooted in her extensive training and commitment to improving healthcare systems and patient support services.

Publication Profile

ORCID

Educational Background

Sr. Gotfrida has a diverse educational background, beginning with a Diploma in Nursing from Huruma School of Nursing. She earned a Bachelor of Science in Nursing from Tumaini University in 2010 and later an MSc in Nursing Education from Kenya Methodist University in 2014. Currently, she is pursuing advanced research in breast cancer at CUHAS (2022-2025). Her education reflects a commitment to deepening her expertise and advancing nursing education, with each academic milestone equipping her with the skills necessary for teaching, curriculum development, and improving healthcare delivery in her community.

Experience

With over 20 years of experience, Sr. Gotfrida has served in numerous capacities, including assistant lecturer, coordinator, and quality assurance officer. She began as a healthcare administrator and HIV/AIDS counselor in Tanzania’s health centers and later transitioned into academic roles at Tanga Nursing School and CUHAS. Her experience includes coordinating programs for midwifery and nursing education, acting as principal of nursing schools, and developing educational frameworks. This extensive experience in both teaching and administration has empowered her to lead healthcare training initiatives, enhancing the quality of nursing education and improving healthcare standards in Tanzania.

Research Focus

Sr. Gotfrida’s current research focus is breast cancer, an area she has been exploring since 2022 through her studies at CUHAS. Her research aims to improve early diagnosis, treatment options, and patient outcomes in cancer care, particularly within resource-limited settings. Her experience in palliative care and counseling for cancer patients further informs her approach, emphasizing compassionate care and patient education. She also explores integrated reproductive health and quality assurance in healthcare, with a particular interest in empowering healthcare providers to deliver competent, respectful maternity and cancer care services.

Awards and honors

Throughout her career, Sr. Gotfrida has been recognized for her contributions to nursing education and healthcare quality improvement. She has been honored with leadership roles, including quality assurance officer and coordinator of various healthcare programs. Her achievements in curriculum development, midwifery training, and healthcare management reflect her commitment to excellence in nursing education. Although specific formal awards are not listed, her influence and respected positions within Tanzanian healthcare institutions highlight her dedication to advancing the nursing profession and improving healthcare outcomes for communities.

Conclusion

Sr. Gotfrida M. Marandu possesses an impressive blend of academic qualifications, practical experience, and extensive training in healthcare education, quality assurance, and nursing management. Her ongoing research on breast cancer and her broad expertise in health systems management make her a strong candidate for a research-focused award. However, she may further strengthen her profile by publishing more research and refining her focus within a specialized area of study. With these improvements, she would be well-positioned to be recognized as a leading researcher in her field.

Publication Top Notes

Title: “Evaluation of Breast Health Promotion Intervention Among Catholic Nuns in Lake Zone, Tanzania”

Citation: “Evaluation of Breast Health Promotion Intervention Among Catholic Nuns in Lake Zone, Tanzania.” European Journal of Breast Health, 2024, doi:10.4274/ejbh.galenos.2024.2024-1-10.

Title: “Factors Associated With Uptake of Breast Cancer Screening Among Catholic Nuns in Lake Zone, Tanzania”

  • Authors: Not specified in the provided information
  • Year: 2024
  • Journal: International Journal of Breast Cancer
  • DOI: 10.1155/2024/5024392
  • Source: Crossref

Citation: “Factors Associated With Uptake of Breast Cancer Screening Among Catholic Nuns in Lake Zone, Tanzania.” International Journal of Breast Cancer, 2024, doi:10.1155/2024/5024392.

Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Posted on by ScienceFather

Prof. Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Prof. Ammu Kutty Radhakrishnan, Monash University Malaysia, Malaysia

 

Prof. Ammu Kutty Radhakrishnan is a distinguished immunologist with a PhD from the University of Cambridge (1994), an MSc in Biochemistry (1990), and a BSc (First Class Honours) from the University of Malaya (1987). Currently, a Professor of Immunology at Monash University Malaysia, she has over 25 years of academic leadership and research experience. Prof. Ammu specializes in immunotherapy and food as medicine research, serving as Head of this research strength. Her career spans significant roles at International Medical University and Oxford. She is a research consultant, active in COVID-19 vaccine efforts, and supervises PhD and MSc students. 🌿🧬📚

 

Publication Profile

Google Scholar

Academic Excellence

Prof. Ammu Kutty Radhakrishnan has an exceptional academic background, with a PhD in Immunology from the University of Cambridge (1994) and degrees in Biochemistry from the University of Malaya. Her education forms a solid foundation for her expertise in immunology and biomedical sciences, contributing to her distinguished career.

Professional Experience

Prof. Radhakrishnan has held key roles, such as Professor at Monash University Malaysia and the International Medical University (IMU). Her leadership in academic programs, such as head of the Food as Medicine Research Strength and chief examiner roles, showcases her commitment to advancing education and research.

Research Contributions

Prof. Radhakrishnan has supervised numerous PhD and Master’s students, guiding 39 doctoral and 20 master’s research projects to completion. Her extensive research supervision experience highlights her dedication to fostering scientific inquiry and innovation. Additionally, her collaborative efforts with industry partners demonstrate her ability to apply research to real-world problems.

Conclusion

Prof. Ammu Kutty Radhakrishnan’s outstanding academic credentials, extensive research supervision, leadership roles, and global health contributions, she is an ideal candidate for the Best Researcher Award. Her work in immunology, biomedicine, and collaboration with industry partners demonstrates her excellence in both academic and applied research, making her a worthy contender for this prestigious recognition.

 

Publication Top Notes  

  • Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals (2010) – 292 citations 🧪
  • Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 (1994) – 259 citations 🧬
  • Rind of the rambutan, Nephelium lappaceum, a potential source of natural antioxidants (2008) – 193 citations 🍇
  • Current concepts of neurodegenerative mechanisms in Alzheimer’s disease (2018) – 176 citations 🧠
  • Bioactive Compounds: Natural Defense Against Cancer? (2019) – 169 citations 🌿
  • Protective mechanisms of flavonoids in Parkinson’s disease (2015) – 162 citations 🧑‍⚕️
  • Tocotrienol research: past into present (2012) – 157 citations 🌰
  • Standardised Mangifera indica extract is an ideal antioxidant (2009) – 149 citations 🥭
  • Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease (2020) – 128 citations 🚀
  • Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice (2004) – 126 citations 🧫
  • Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity (2013) – 124 citations 🧪

 

Ken Kato | Oncology Award | Excellence in Research

Posted on by ScienceFather

Dr. Ken Kato | Oncology Award | Excellence in Research

Dr. Ken Kato, National Cancer Center Hospital, Japan

Dr. Ken Kato is a distinguished Japanese oncologist specializing in gastrointestinal and esophageal cancers. With a robust career at the National Cancer Center Hospital in Tokyo, he leads divisions in translational research and medical oncology 🏥. Holding both an M.D. and a Ph.D. from prestigious institutions 🎓, Dr. Kato has a notable presence in clinical and research domains, with expertise in molecular targets and immunotherapy for cancer 🧬. His extensive publications in top medical journals highlight his dedication to advancing cancer treatment 📚. Dr. Kato is also an active member of several professional societies worldwide 🌏.

Publication profile

Scopus

Education

Dr. Kato earned his Ph.D. from Kyushu University in 2001 and his M.D. in 1995. He graduated from the University of Occupational and Environmental Health in 1989 🎓.

Research Focus

Dr. Ken Kato is a leading researcher in gastrointestinal and esophageal cancers, focusing primarily on early detection, treatment, and the molecular mechanisms of these malignancies 🧬. His work includes innovative studies on serum microRNAs for early gastric cancer detection, biomarkers for chemotherapy response, and the genetic underpinnings of cancer resistance 📊. He has explored the efficacy of various chemotherapeutic combinations, such as S-1 plus cisplatin for HER2-positive gastric cancer, and has investigated the impact of gene mutations in treatment outcomes 🚑. Dr. Kato’s research aims to advance precision medicine in oncology, improving patient survival and treatment efficacy 🌟.

Publication Top Notes

  • A novel combination of serum microRNAs for the detection of early gastric cancer – Abe, S., Matsuzaki, J., Sudo, K., … Saito, Y., Ochiya, T. Gastroenterological Endoscopy, 2021, 63(6), pp. 1310 📅, Cited by: 0 🔍
  • ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy – Takahashi, T., Yamahsita, S., Matsuda, Y., … Nagino, M., Ushijima, T. Journal of Cancer Research and Clinical Oncology, 2015, 141(3), pp. 453–463 📅, Cited by: 21 📊
  • Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer – Honma, Y., Shimada, Y., Takashima, A., … Sekine, S., Kushima, R. International Journal of Clinical Oncology, 2014, 19(5), pp. 863–870 📅, Cited by: 3 📈
  • Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer – Takahashi, N., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. BMC Research Notes, 2014, 7(1), 271 📅, Cited by: 41 🔬
  • Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection – Shoji, H., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. Cancer Science, 2014, 105(8), pp. 1002–1007 📅, Cited by: 24 🧬
  • Combined Assessment of Endothelial Growth Factor Receptor Dual Color In Situ Hybridization and Immunohistochemistry with Downstream Gene Mutations in Prediction of Response to the Anti-EGFR Therapy for Patients with Metastatic Colorectal Cancer – Takahashi, N., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. Archives of Medical Research, 2014, 45(5), pp. 366–374 📅, Cited by: 7 🔍
  • A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI) – Kato, K., Muro, K., Ando, N., … Nagai, K., Kato, H. Esophagus, 2014, 11(3), pp. 183–188 📅, Cited by: 30 🩺
  • Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: Combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912 – Takashima, A., Boku, N., Kato, K., … Shimada, Y., Ohtsu, A. Gastric Cancer, 2014, 17(3), pp. 522–528 📅, Cited by: 26 📊
  • Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma – Hayashi, H., Arao, T., Matsumoto, K., … Nishio, K., Yamada, Y. Oncotarget, 2014, 5(9), pp. 2588–2595 📅, Cited by: 33 🧪
  • Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer – Makazu, M., Kato, K., Takisawa, H., … Yamada, Y., Shimada, Y. Diseases of the Esophagus, 2014, 27(1), pp. 42–49 📅, Cited by: 31 🩹